2025 saw strong revenue and EBITDA growth, significant deleveraging, and improved cash flow, driven by portfolio simplification and operational efficiency. The outlook for 2026 is positive, with continued focus on diagnostics, margin expansion, and disciplined capital allocation.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.